If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHerald Investment Trust Regulatory News (HRI)

Share Price Information for Herald Investment Trust (HRI)

Share Price is delayed by 15 minutes
Get Live Data
3,080.00    -30.00 (-0.96%)
Bid:
3,075.00
Ask:
3,090.00
Spread: 15.00 (0.488%)
Market Cap: £588.38m
HRI Live PriceLast checked at - London Stock Exchange

Intraday Herald Investment Trust Share Chart

Completion of Tender Offer

Today 17:34

RNS Number : 7839L
Herald Investment Trust PLC
09 July 2026
 

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO MAY RESULT IN THE CONTRAVENTION OF ANY REGISTRATION OR OTHER LEGAL REQUIREMENT OF SUCH JURISDICTION OR OF THE UK.

9 July 2026

For immediate release

HERALD INVESTMENT TRUST PLC

(the "Company" or "Herald") 

Completion of Tender Offer

 

Further to the results of the Tender Offer announced by the Company on 7 July 2026, J.P. Morgan Cazenove and Singer Capital Markets have today purchased a total of 28,755,072 Shares pursuant to the Tender Offer (the "Tendered Shares"), and the Company has subsequently repurchased such Tendered Shares pursuant to the Repurchase Agreements, in each case at the applicable Tender Prices previously announced.

 

Simultaneously, Qualifying In Specie Shareholders who successfully elected for the In Specie Option have today had their entitlements to the In Specie Tender Price settled by way of a transfer of the relevant proportion of the Portfolio Assets of equivalent value in accordance with the relevant Portfolio Sale Agreements.

 

Eligible Shareholders who successfully elected for the Cash Option will have their entitlements to the Cash Tender Price settled, by payments through CREST or by the despatch of cheques (as applicable), by 23 July 2026.

 

Further details of any remaining administrative matters in connection with the Tender Offer are set out in the Tender Offer circular published by the Company on 2 June 2026 (the "Circular"). Capitalised terms used throughout this announcement shall have the meanings given to them in Part 8 (Definitions) of the Circular, unless the context requires otherwise.

 

Update on Investment Management Arrangements

 

Following completion of the Tender Offer, it remains the Company's expectation that, pursuant to the Conditional Management Agreement, the Company will appoint Aberdeen Investments ("Aberdeen") as its AIFM, on terms substantially consistent with existing arrangements (which include provision for Aberdeen to provide company secretarial and administration services), with effect on or around 1 August 2026.

Upon Aberdeen being appointed as AIFM, the Company's existing Management Agreement with HIML will terminate.

As set out in the Circular, a number of HIML employees who are currently involved in the day-to-day management and administration of the Company are expected to transfer to Aberdeen upon the Conditional Management Agreement taking effect.

This group includes Katie Potts, who will remain as the Company's investment manager, and a number of her current investment management team. There will be no changes to the Company's investment mandate or management fee rates.

Total Voting Rights

 

All Tendered Shares repurchased by the Company in connection with the Tender Offer have been cancelled.

 

In accordance with the FCA's Disclosure Guidance and Transparency Rules, the Company announces that as at 9 July 2026, following completion of the Tender Offer, the issued share capital of the Company consisted of 19,103,395 Shares (being ordinary shares of 25 pence each) and there were no Shares held in treasury.

 

On a poll held at a general meeting of the Company, each Share carries the right to one vote and, accordingly, the total number of voting rights in the Company as at close of business on 9 July 2026, following completion of the Tender Offer, was 19,103,395.

 

The figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

Enquiries:

Herald Investment Trust plc

via Camarco

Andrew Joy (Chairman)

Camarco (Media enquiries)

+44 (0)20 3757 4980

Billy Clegg / Ben Woodford / Elfie Kent

Herald@camarco.co.uk

J.P. Morgan Cazenove (Financial Adviser)

+44 (0)20 3493 8000

William Simmonds / Rupert Budge

Singer Capital Markets (Corporate Broker)

+44 (0)20 7496 3000

Alan Geeves / Sam Greatrex / William Gumpel (Sales)

James Maxwell (Investment Banking)

NSM Funds (UK) Limited (Company Secretary)

HIT@nsm.group

Brian Smith / Shilla Pindoria

 

Herald Investment Management Limited (via Hudson Sandler)

Michael Sandler

+44 (0)20 7796 4133

 

Important Information

The person responsible for arranging for the release of this announcement on behalf of the Company is NSM Funds (UK) Limited, the company secretary.

 

The Company's LEI number is 213800U7G1ROCTJYRR70.

J.P. Morgan Securities plc (which conducts its UK investment banking activities as J.P. Morgan Cazenove) ("J.P. Morgan Cazenove") is authorised in the United Kingdom by the Prudential Regulation Authority of the Bank of England (the "PRA") and regulated by the PRA and the Financial Conduct Authority (the "FCA"). Singer Capital Markets Securities Limited ("Singer Capital Markets") is authorised and regulated in the United Kingdom by the FCA. J.P. Morgan Cazenove and Singer Capital Markets are exclusively advising the Company and are not advising any other person or treating any other person as their respective clients in relation to the Tender Offer, or the matters referred to in this announcement, and will not be responsible to anyone other than the Company for providing the protections afforded to customers of J.P. Morgan Cazenove and Singer Capital Markets (respectively) nor for providing advice in relation to the Tender Offer or the matters referred to in this announcement. Nothing in this paragraph shall serve to exclude or limit any responsibilities which J.P. Morgan Cazenove or Singer Capital Markets may have under FSMA or the regulatory regime established thereunder.

NOTICE TO U.S. SHAREHOLDERS

The Tender Offer relates to securities of a non-U.S. company listed on the London Stock Exchange and is subject to the disclosure requirements, rules and practices applicable to companies listed in the United Kingdom, which differ from those of the United States in certain material respects. A circular has been prepared in accordance with UK style and practice for the purpose of complying with the laws of England and Wales and the rules of the FCA and of the London Stock Exchange. The Tender Offer is not subject to the disclosure or other procedural requirements of Regulation 14D under the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Tender Offer will be made in the United States pursuant to Section 14(e) of, and Regulation 14E under, the Exchange Act, subject to the exemptions provided by Rule 14d-1(d) thereunder, and otherwise in accordance with the requirements of the rules of the FCA and the London Stock Exchange. Accordingly, the Tender Offer would be subject to disclosure and other procedural requirements that are different from those applicable under U.S. domestic tender offer procedures and law. The Company is not listed on an American securities exchange, is not subject to the periodic reporting requirements of the Exchange Act and is not required to, and does not, file any reports with the SEC thereunder.

It may be difficult for U.S. shareholders to enforce certain rights and claims arising in connection with the Tender Offer under U.S. federal securities laws, because the Company is located outside the United States, and its officers and directors reside outside the United States. It may not be possible to sue a non-U.S. company or its officers or directors in a non-U.S. court for violations of U.S. securities laws. It also might not be possible to compel a non-U.S. company or its affiliates to subject themselves to a U.S. court's judgment.

To the extent permitted by applicable law and in accordance with normal UK practice, the Company, J.P. Morgan Cazenove, Singer Capital Markets or any of their respective affiliates may make certain purchases of, or arrangements to purchase, shares of the Company outside the United States, other than pursuant to the Tender Offer, before or during the period in which the Tender Offer remains open for acceptance, including sales and purchases of shares effected by J.P. Morgan Cazenove and/or Singer Capital Markets acting as market maker in the shares.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEFZGGNVLMGVZM
Date   Source Headline
9th Jul 20265:34 pmRNSCompletion of Tender Offer
9th Jul 202611:25 amRNSNet Asset Value(s)
8th Jul 202612:15 pmRNSNet Asset Value(s)
7th Jul 20265:57 pmRNSResult of Tender Offer
7th Jul 202611:45 amRNSNet Asset Value(s)
6th Jul 202610:26 amRNSNet Asset Value(s)
3rd Jul 202611:10 amRNSNet Asset Value(s)
2nd Jul 202611:46 amRNSNet Asset Value(s)
1st Jul 202612:12 pmRNSNet Asset Value(s)
30th Jun 20266:15 pmRNSResult of General Meeting
30th Jun 20266:11 pmRNSResult of AGM
30th Jun 202611:35 amRNSNet Asset Value(s)
29th Jun 202611:37 amRNSNet Asset Value(s)
26th Jun 202611:44 amRNSNet Asset Value(s)
26th Jun 202611:13 amRNSForm 8.3 - Aptitude Software Group plc
25th Jun 202611:30 amRNSNet Asset Value(s)
24th Jun 202611:36 amRNSNet Asset Value(s)
24th Jun 202610:24 amRNSSTATISTICS AND PERFORMANCE REPORT
23rd Jun 202611:08 amRNSNet Asset Value(s)
23rd Jun 20267:00 amRNSDirectorate change
22nd Jun 202611:25 amRNSNet Asset Value(s)
19th Jun 202611:42 amRNSNet Asset Value(s)
18th Jun 202611:58 amRNSNet Asset Value(s)
18th Jun 202611:32 amRNSForm 8.3 - Aptitude Software Group plc
17th Jun 202612:03 pmRNSForm 8.3 - Checkit plc
17th Jun 202611:57 amRNSNet Asset Value(s)
16th Jun 202611:24 amRNSNet Asset Value(s)
16th Jun 20269:54 amRNSForm 8.3 - Aptitude Software Group plc
15th Jun 202611:48 amRNSForm 8.3 - Checkit plc
15th Jun 202611:11 amRNSNet Asset Value(s)
12th Jun 202611:33 amRNSNet Asset Value(s)
11th Jun 202611:16 amRNSNet Asset Value(s)
10th Jun 202611:34 amRNSNet Asset Value(s)
9th Jun 202611:34 amRNSNet Asset Value(s)
8th Jun 202611:25 amRNSNet Asset Value(s)
5th Jun 202611:32 amRNSNet Asset Value(s)
4th Jun 202611:23 amRNSNet Asset Value(s)
3rd Jun 202611:46 amRNSNet Asset Value(s)
2nd Jun 202611:47 amRNSNet Asset Value(s)
2nd Jun 20267:00 amRNSTender Offer Circular and Notice of AGM
1st Jun 20261:31 pmRNSNet Asset Value(s)
29th May 202611:55 amRNSNet Asset Value(s)
28th May 202611:41 amRNSNet Asset Value(s)
27th May 202612:06 pmRNSNet Asset Value(s)
26th May 202611:00 amRNSNet Asset Value(s)
22nd May 202611:19 amRNSNet Asset Value(s)
21st May 20263:23 pmRNSHolding(s) in Company
21st May 202611:06 amRNSNet Asset Value(s)
20th May 202611:35 amRNSNet Asset Value(s)
19th May 202611:33 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.